News & Media

12 January 2025

Research led by N2CR member Dr. Cheok Chit Fang found that the tumour suppressor protein p53 protects DNA during replica...

12 January 2025

Gold nanoparticles (NPs) are promising for cancer therapy due to their versatile properties. However, their interactions...

6 December 2024

CIITA is the master regulator of MHC class-II immune genes that are important for defense mechanism against infections a...

25 November 2024

Chemotherapy, although the first line of defense in cancer treatment, is indiscriminate and is damaging to the entire bo...

18 November 2024

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the first auth...

4 November 2024

Detecting cancer-driving mutations is crucial for understanding cancer and developing treatments. Existing prediction to...

30 October 2024

Led by N2CR member A/Prof Polly Chen, this research highlights the crucial role of ‘death associated protein 3’ (DAP...

9 October 2024

Relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) is challenging to treat. Outcome for such patients is di...

5 October 2024

A recent phase l trial evaluated the safety and efficacy of combining pressurised intraperitoneal aerosol chemotherapy-o...